Chronic Kidney Disease News

The FDA granted fast track designation for Tecarfarin, a novel cardiorenal therapy by Cadrenal Therapeutics, to prevent systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.

The FDA accepted a supplemental new drug application for Jardiance, empagliflozin tablets, which may reduce kidney disease progression and cardiovascular death in adults with chronic kidney disease, according to the press release.

Using intensive blood pressure control in patients with stages 4 to 5 chronic kidney disease may delay the onset of kidney replacement therapy, according to data published in the Journal of the American Society of Nephrology.

Measuring cystatin C-based eGFR strongly correlates with creatinine eGFR, but it can also have a significant impact on the staging of chronic kidney disease, according to data published in Kidney Medicine.

Time-dependent dysnatremias was significantly associated with mortality among patients with chronic kidney disease, according to data published in Kidney Medicine.

The first validated tool has been developed to assess pain and discomfort specific to autosomal dominant polycystic kidney disease, according to data presented in the Clinical Journal of the American Society of Nephrology.

Researchers identified functionally relevant risk factors for pediatric primary focal segmental glomerulosclerosis in African American children, according to data published in the American Journal of Kidney Diseases.

The Kidney Disease Improving Global Outcomes updated the clinical practice guidelines for treating patients with diabetes and chronic kidney disease to recommend new practices, according to a press release.

Among Japanese patients with atrial fibrillation, elevated urinary protein may be an independent risk factor for HF events, according to a study published in European Heart Journal - Quality of Care and Clinical Outcomes.

Among patients on incident peritoneal dialysis, higher plasma omeintin-1 level quartile correlates with reduced subsequent hospital admissions and shorter hospital stays, according to data published in Kidney Medicine.